| Particulars |
|
|
|
|
Company Name
| Emcure Pharmaceuticals Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
189.66 |
B.V. (₹) |
195.60 |
| Sales(₹ Cr.) |
5,243.19 |
NP (₹ Cr.) |
751.82 |
| NP Var% |
161.00 |
Div% |
36.00 |
| CPS(₹) |
52.60 |
EPS (₹) |
39.60 |
| Traded Value(₹ Lakhs) |
848.24 |
52 Week High |
1,944.00 |
| 52 Week Low |
1,230.00 |
Price BSE |
1,882.00 |
| Price NSE |
1,880.00 |
Market Capital (₹ Cr.) |
35,692.03 |
| P/C Ratio |
35.70 |
P/E Ratio |
47.50 |
| Price Vs.BV |
9.62 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,467.70 |
| NP(₹ Cr.) |
228.07 |
NP Var % |
63.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
3,847.63 |
| OPM |
13.36 |
NP |
232.25 |
| NP Var% |
160.51 |
EPS |
39.64 |
| PE |
47.47 |
|
|